CG Oncology (CGON) Preferred Dividend Payments (2023)

CG Oncology's (CGON) quarterly Preferred Dividend Payments came in at $410000.0 in Q3 2023, down 89.14% on a QoQ basis from $3.8 million in Q2 2023.

CG Oncology (CGON) Preferred Dividend Payments (2023) Analysis & Trends

CG Oncology (CGON) has 1 years of Preferred Dividend Payments data on file, last reported at $410000.0 in Q3 2023.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $410000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2024 was $410000.0 (changed N/A YoY) and the FY2023 annual result came in at $410000.0, changed N/A from the prior year.
Preferred Dividend Payments declined to $410000.0 in Q3 2023, from $3.8 million in the prior quarter.
In the past five years, Preferred Dividend Payments ranged from a high of $3.8 million in Q2 2023 to a low of $410000.0 in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-
10	CG Oncology	6.63 Bn	6.63 Bn	-2.77 Mn	-

Download Data